<i>De novo</i> hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.

Bedi, Harjot K; Trasolini, Roberto; Lowe, Christopher F; Hussaini, Trana; Bigham, Mark; Ritchie, Gordon; Yoshida, Eric M

De novo hepatitis B surface antigen (HBsAg)-positive, core antibody (anti-HBc)-negative, hepatitis B virus infection post-liver transplant from an anti-HBc, HBsAg-negative donor.

Bedi, Harjot K; Trasolini, Roberto; Lowe, Christopher F; Hussaini, Trana; Bigham, Mark; Ritchie, Gordon; Yoshida, Eric M.

Afiliação

Bedi HK; Department of Medicine, University of British Columbia, Vancouver BC, Canada.
Trasolini R; Department of Medicine, University of British Columbia, Vancouver BC, Canada.
Lowe CF; Division of Gastroenterology, University of British Columbia, Vancouver BC, Canada.
Hussaini T; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada.
Bigham M; Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver BC, Canada.
Ritchie G; Fraser Health Authority, Surrey BC, Canada.
Yoshida EM; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver BC, Canada.

Hepatol Forum ; 2(3): 117-119, 2021 Sep.

Article em En | MEDLINE | ID: mdl-35784901